{"pmid":32231220,"title":"Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension.","text":["Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension.","Hypertens Res","Li, Gang","Hu, Rui","Zhang, Xuejiao","32231220"],"journal":"Hypertens Res","authors":["Li, Gang","Hu, Rui","Zhang, Xuejiao"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32231220","week":"202014|Mar 30 - Apr 05","doi":"10.1038/s41440-020-0433-1","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662899337736224769,"score":7.3910046,"similar":[{"pmid":32222168,"title":"Antihypertensive drugs and risk of COVID-19?","text":["Antihypertensive drugs and risk of COVID-19?","Lancet Respir Med","Brown, Joshua D","32222168"],"journal":"Lancet Respir Med","authors":["Brown, Joshua D"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32222168","week":"202014|Mar 30 - Apr 05","doi":"10.1016/S2213-2600(20)30158-2","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662715354796785664,"score":47.4675},{"pmid":32222167,"title":"Antihypertensive drugs and risk of COVID-19?","text":["Antihypertensive drugs and risk of COVID-19?","Lancet Respir Med","Lo, Kevin Bryan","McCullough, Peter A","Rangaswami, Janani","32222167"],"journal":"Lancet Respir Med","authors":["Lo, Kevin Bryan","McCullough, Peter A","Rangaswami, Janani"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32222167","week":"202014|Mar 30 - Apr 05","doi":"10.1016/S2213-2600(20)30156-9","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662715354797834240,"score":47.4675},{"pmid":32222166,"title":"Antihypertensive drugs and risk of COVID-19?","text":["Antihypertensive drugs and risk of COVID-19?","Lancet Respir Med","Tignanelli, Christopher J","Ingraham, Nicholas E","Sparks, Matthew A","Reilkoff, Ronald","Bezdicek, Tamara","Benson, Bradley","Schacker, Timothy","Chipman, Jeffrey G","Puskarich, Michael A","32222166"],"journal":"Lancet Respir Med","authors":["Tignanelli, Christopher J","Ingraham, Nicholas E","Sparks, Matthew A","Reilkoff, Ronald","Bezdicek, Tamara","Benson, Bradley","Schacker, Timothy","Chipman, Jeffrey G","Puskarich, Michael A"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32222166","week":"202014|Mar 30 - Apr 05","doi":"10.1016/S2213-2600(20)30153-3","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662715354797834241,"score":47.4675},{"pmid":32171062,"title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","text":["Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","Lancet Respir Med","Fang, Lei","Karakiulakis, George","Roth, Michael","32171062"],"journal":"Lancet Respir Med","authors":["Fang, Lei","Karakiulakis, George","Roth, Michael"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32171062","week":"202011|Mar 09 - Mar 15","doi":"10.1016/S2213-2600(20)30116-8","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662334543683649538,"score":44.49906},{"pmid":32213760,"title":"Facts and reflections on COVID-19 and anti-hypertensives drugs.","text":["Facts and reflections on COVID-19 and anti-hypertensives drugs.","Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it.","Drug Discov Ther","Marin, Gustavo H","32213760"],"abstract":["Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it."],"journal":"Drug Discov Ther","authors":["Marin, Gustavo H"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32213760","week":"202013|Mar 23 - Mar 29","doi":"10.5582/ddt.2020.01017","keywords":["ACE","ATII-RB","Anti-hypertensive drugs","COVID-19","SARS-CoV-2"],"source":"PubMed","locations":["Spain"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1662445896473772033,"score":43.364983}]}